In cancer care, developing a personalized care plan for each patient is crucial, especially during the initial diagnosis phase. This phase is not only the starting point for medical record collection and diagnosis but also a critical moment for determining the direction of future care. Scientific testing methods can help medical teams fully understand a patient’s health status, cancer risks, metabolic characteristics, and more, thereby establishing a personalized care baseline. These tests provide real-time data that serve as an important reference for future care adjustments.

1. Genetic Testing: Decoding Genetic Risks and Individual Differences

Genetic testing can help medical teams understand the patient’s genetic background, particularly genetic mutations, susceptibilities, and possible treatment responses related to cancer. This data can offer predictions regarding the patient’s response to various treatments, such as chemotherapy, targeted therapy, etc. Through genetic sequencing technologies like the Onco-D-clare test provided by RGCC, doctors can precisely identify the patient’s genetic traits and formulate a personalized care plan.

2. Circulating Tumor Cell (CTC) Testing: Real-time Monitoring of Cancer Progression

Circulating tumor cells (CTCs) are cancer cells that detach from the primary tumor and enter the bloodstream, reflecting changes in cancer progression within the body. RGCC’s CTC testing technology helps medical teams promptly detect the risk of micro-metastasis or recurrence, allowing for more flexible care adjustments. This test not only provides valuable baseline data at initial diagnosis but also enables dynamic monitoring as treatment progresses.

3. Heavy Metal Testing: Understanding the Burden of Environmental Toxins

Environmental toxins, especially the accumulation of heavy metals, pose a potential threat to cancer patients’ health. Conducting heavy metal testing helps doctors understand whether the patient has excessive accumulation of harmful substances like lead, mercury, or cadmium. These toxins can not only worsen liver and kidney function but also interfere with the immune system and treatment process. By measuring these indicators, medical teams can specifically adjust the patient’s detox support plan.

4. Immune Function Testing: Assessing Immune Status

Cancer often accompanies abnormalities in immune function. Immune function testing allows doctors to evaluate the patient’s immune status and determine if there is immune suppression. In certain patients, immune system suppression may prevent effective cancer cell elimination, whereas others may have a stronger immune response, leading to better treatment outcomes.

5. Nutritional and Metabolic Testing: Adjusting Diet and Lifestyle

The nutritional status of cancer patients is a critical factor influencing treatment effectiveness and quality of life. Comprehensive nutritional testing at the initial diagnosis stage can help understand any nutritional deficiencies in the patient and adjust the diet accordingly or supplement necessary nutrients. For high-risk patients, professional nutritional support can help improve immune function and reduce side effects during treatment.

Conclusion

Initial diagnosis testing helps medical teams gain a comprehensive understanding of a patient’s health status and provides strong data support for future treatment and care. Through methods such as genetic testing, circulating tumor cell testing, heavy metal testing, immune function testing, and nutritional and metabolic testing, doctors can more accurately identify the patient’s needs and establish a personalized care baseline, thereby developing the best treatment strategy and care plan. Such comprehensive assessments can improve patient outcomes and quality of life, laying a solid foundation for their journey toward health.

References

1. Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143-3153. doi: 10.1016/j.bbagen.2012.09.012.
2. Pizzorno J. Glutathione! Integr Med (Encinitas). 2014;13(1):8-12. PMID: 26770186.
3. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489-492. doi: 10.1093/jn/134.3.489.
4. Ballatori N, Krance SM, Marchan R, Hammond CL. Molecular mechanisms of hepatic glutathione transport. Annu Rev Pharmacol Toxicol. 2009;49:95-113. doi: 10.1146/annurev.pharmtox.051208.165937.
5. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003;57(3-4):145-155. doi: 10.1016/S0753-3322(03)00043-X.
6. Forman HJ, Zhang H, Rinna A. Glutathione: Overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12. doi: 10.1016/j.mam.2008.08.006.
7. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem. 2007;113(4-5):234-258. doi: 10.1080/13813450701744368.

Medical Disclaimer:

The information provided in this article is for educational and reference purposes only and does not constitute medical advice nor should it be used as a substitute for professional medical diagnosis, treatment, or advice. ALWAYS CONSULT ANY QUESTIONS YOU MAY HAVE ABOUT YOUR MEDICAL CONDITION OR MEDICAL PROBLEM ALWAYS CONSULT YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROFESSIONAL. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be construed as such. If you develop symptoms or require medical assistance, please contact a healthcare professional promptly.